Molecular diagnostics
Develops portable genetic testing systems and the assays that run on them, aimed at detecting medical conditions from patient samples.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Genomtec is a Polish life-science company that develops molecular diagnostics tools for detecting genetic material from pathogens and other biological samples. Its core work centers on laboratory and point-of-care testing systems, including the test cartridges and instruments needed to run them. The company sells its technology into healthcare and diagnostics, where fast and accurate identification of infections matters.
The company makes money by selling diagnostic devices, assay kits, and related consumables used with those systems. In practice, that means hospitals, laboratories, clinics, and research customers buy the hardware to run the tests and then keep buying the single-use reagents and cartridges needed for each test. This creates a model tied not just to one-time equipment sales, but also to repeat usage of its testing platform.
What sets Genomtec apart is that it sits at the intersection of biotechnology, diagnostics, and medical hardware. Instead of offering a broad menu of unrelated products, it focuses on building a compact testing platform that can bring genetic analysis closer to the patient or the lab bench. That makes it a specialist supplier in a value chain where speed, test accuracy, and ease of use are central buying criteria.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more